risk factors for its development. The purpose of the study was not to create and test a "structured" screening program, but rather to take a "snapshot" of the present practices, which might help estab lish such a screening policy for CKD. A total of 1146 patients have been admitted to the ED during the specified period. Most of them (934) had minor clinical problems, which were handled on an outpatient basis. In those patients no further laboratory tests or imaging procedures were performed, except for general physical ex amination, prescription of common drugs (oral antibiotics, pain killers, antipyretic or antidiar rheal agents, etc.) and sometimes minor surgical procedures (because of the carnival period, many patients were young people with minor injuries caused by alcohol overuse). We excluded pregnant women presenting for delivery (n = 12) and pa tients with critical illnesses who were immediate ly transferred to the operation theatre or inten sive care unit without detailed diagnosis or blood sampling in the ED (n = 22). This left us with 178 patients who were preliminary diagnosed in the ED and later were nonelectively admitted to any of the hospital wards. We excluded patients with previously diagnosed CKD (based on his tory and medical records; n = 2). Thus, the final study group comprised 176 patients: 75 women (43%) and 101 men (57%) aged between 18 and 91 years (mean 59.6 ±20.3 years).
We investigated the frequency of those pro cedures performed in the ED, which may help identify the presence of CKD or the risk factors for its development. These included blood pres sure measurement, urinalysis, measurement of serum urea, creatinine, glucose, potassium, and estimated GFR (eGFR) calculation. We carefully reviewed all medical records in the ED as well as the central laboratory database to obtain the true image of the current practices. The ED staff was not aware of the ongoing analysis.
All bio chemical analyses were performed us ing the Cobas 6000 Analyser equipment (Roche Diagnostics, Basel, Switzerland), which utilizes the Jaffe method to measure serum creatinine lev els. Blood pressure was measured with the certi fied Omron M6 Comfort electronic sphygmoma nometer (Omron Ltd., Kyoto, Japan). eGFR was calculated using the abbreviated fourparameter Modification of Diet in Renal Disease (MDRD) formula; it has been calculated auto matically by the laboratory in every patient with blood sam pled for creatinine levels.
statistical analysis Statistical analysis of the data was performed using the Statistica 8.0 software (StatSoft Inc., Tulsa, Oklahoma, United States). The ShapiroWilk's Wtest for normality was used for data distribution analysis. Because all the variables were normally distributed, the results were presented as mean ± standard deviation. For inter group comparisons, the t test for indepen dent variables was used. We considered a P value of less than 0.05 as statistically significant. patients with overt disease or to lower the risk of death. This applies to such treatment modalities as erythropoiesisstimulating agents, phosphate binding drugs, lipidlowering therapy, angiotensin converting enzyme inhibitors, etc. 2,3 Therefore, CKD patients should be diagnosed as early as pos sible, so that all the available therapeutic mea sures can be implemented to slow down the pro gression of renal disease and to prevent the de velopment of more advanced stages.
For many years, renal community has made efforts to identify CKD patients at the earliest possible stage, by implementing different screen ing programs. There have been populationbased programs and also more "targeted" ones, namely those analyzing patient groups with certain risk factors, such as hypertension, diabetes, ethnicity, or CKD in family history. The prevalence of CKD in these programs varies from 10% to more than 50% and, obviously, the more targeted is the search, the higher the chance to identify patients at risk.
4-8 Searching for asymptomatic patients with possible CKD at early stages seems a diffi cult task, and it may not be very efficient (includ ing costefficiency), especially in the population based studies.
We assumed that the emergency department (ED) may be the right place to search for CKD. The advantage of screening for CKD in this setting is that no search is required, because patients (of ten with several comorbidities and risk factors for CKD) come on their own. On the other hand, this is an example of "nontargeted" screening, be cause no prespecified criteria were applied before the examination. The aim of the present study was to investigate routine ED practices, which may allow to identify patients with CKD or with major risk factors for its development.
PAtIEnts And mEthods Between January 1 and January 31, 2010, we analyzed the current clinical practices at the ED of a large, universityaffi liated hospital serving the population of about 200,000. This analysis may become useful in the identi fication of patients with CKD or with certain neurology units were the most frequent destina tions (up to 60% of all admissions).
Blood pressure was measured in the whole study group but recorded in the medical files of only 108 patients (61%). Most of these 108 pa tients were later admitted to the departments of cardiology (44%) and neurology (32%). The mean blood pressure was 148.6 ±35.8 mmHg (systolic) and 83.3 ±17.4 mmHg (diastolic). In 68 patients, (63% of those with known blood pressure) the val ues exceeded 140/90 mmHg.
Serum creatinine was measured in 88 pa tients (50% of the study group). The mean se rum creatinine was 1.3 ±1.4 mg/dl (1.6 ±2.1 for women and 1.1 ±0.5 mg/dl for men); in 24 pa tients it exceeded the upper normal value of 1.2 mg/dl (27.3% of all creatinine samples and almost 14% of the study group). Seventy one percent of patients with elevated serum creati nine were admitted to the departments of neph rology, cardiology, and neurology (with equal distribution between the three). By definition, in all 88 patients with creatinine assessment, MDRDeGFR was also available. Mean eGFR was 78 ±36 ml/min/1.73 m 2 (64 ±34 ml/min/1.73 m 2 for women and 88 ±35 ml/min/1.73 m 2 for men). Fiftyseven eGFR results (64.8% of the patients with assessed eGFR and 32.4% of all patients) were below 90 ml/min/1.73 m 2 , i.e., fulfilled one of the general criteria for CKD diagnosis (of at least stage 2). A detailed distribution of pa tients within the ranges of eGFR and the cor responding stages of CKD are shown in tAbLE 3 (we omitted stage 1 patients on purpose because using the available data we were unable to detect kidney damage in patients with normal eGFRurinalysis was performed only in 5 of 176 sub jects). Because low serum creatinine in older peo ple with sarcopenia may artificially decrease eGFR, we also analyzed the number of patients with eGFR ml/min/1.73 m 2 below 90 and serum creati nine exceeding 1.2 mg/dl to increase the potential "sensitivity" of CKD diagnosis. As can be conclud ed from tAbLE 4, even using more restricted criteria we still were able to identify 24 patients with CKD in stages 2 to 5 (13.6% of all admitted patients). As can be predicted, this adjustment dramatically reduced the number of patients with CKD stage 2, decreased the number of patients with CKD stage 3 by roughly 40%, and did not affect the most ad vanced stages 4 and 5. Differences between pa tients with CKD (eGFR <90 ml/min/1.73 m 2 ) and those without (eGFR >90 ml/min/1.73 m 2 ) are shown in tAbLE 5.
Urea was assessed in 83 subjects (42.2% of the study group) and exceeded the normal value of 50 mg/dl in 32% of the cases. Potassium was measured in 154 patients (87.5% of the study group), and in 82.5% of the assays the results were within the reference range of the local lab oratory (3.5-5.0 mmol/l). Mean serum potassi um was 4.3 ±0.8 mmol/l, with only 10.4% exceed ing 5 mmol/l (however, 2 critically high values of 7.11 and 7.96 mmol/l were observed).
rEsuLts The study group comprised 176 pa tients who presented at the ED and were later admitted nonelectively to one of the hospital wards between January 1 and 31, 2010. We iden tified 11 initial categories of preliminary diag nosis or dominating symptom, on the basis of which the patients were admitted to 11 different wards. The data are summarized in tAbLE 1. As mentioned in the above section, patients with previously diagnosed CKD were excluded from the study. The wards to which emergency patients were admitted are listed in tAbLE 2; cardiology and National Health and Nutrition Examination Survey (NHANES III) database, CKD defined as eGFR between 15 and 60 ml/min (stages 3 and 4) affected 1651 of 8829 patients (18.9% of the stud ied population). In this particular study, the analy sis of CKD prevalence was limited to patients with hypertension; patients with CKD stages 1, 2, and 5 were excluded to avoid misclassification of CKD in its extremes (due to relatively low sensitivity of the MDRD formula in the lowest and highest ranges of GFR). 6 In one of the early NHANES III reports, 11% of all noninstitutionalized adults aged 20 years and older were considered to suf fer CKD of any stage. 8 In the landmark study of Król et al., 4 albuminuria was detected in 15.6% of 2471 people from the Polish general population when the dipstick test was used; it was confirmed in 11.9% by the turbidimetric method. Based on his prescreening, 481 people were consulted by a nephro logist; of these, 96% were diagnosed with any stage of CKD (9% of this population had MDRDeGFR <60 ml/min/1.73 m 2 ).
Our study cannot be directly referred to the populationbased epidemio logical studies. Most of our patients suffered from cardiovascu lar or cerebrovascular diseases and were subse quently admitted to the neurology or cardiology wards, so this was the group with significant co morbidities. Hence, we should rather compare our data to the studies describing populations with such comorbidities. For example, the Kid ney Early Evaluation Program (KEEP) focused more specifically on patients with increased risk of CKD (i.e., hypertension, diabetes, or family his tory of renal disease). According to one of the ear ly KEEP reports, CKD was present in as many as 47.4% of screened patients. 9 As can be expected, presence of CKD was directly associated with in creased risk of cardiovascular events and mor tality. 5 Prevalence of CKD among patients with cardiovascular comorbidity is a wellknown phe nomenon with bidirectional causeeffect rela tionship: patients with atherosclerotic cardio vascular disease have higher risk for developing CKD and CKD is one of the strongest risk fac tors for cardiovascular complications. In a re cently published analysis of the NHANES III, CKD of any stage was found in 63.7% of patients with a history of stroke (and in 34.9% eGFR was <60 ml/min/1.73 m 2 ). Mean eGFR in this popula tion was 69.0 ±20.8 ml/min/1.73 m 2 . 10 In a recent report from China, CKD was diagnosed in 34.1% of patients who were at least 50 years old and had a history of coronary artery disease, stroke, pe ripheral vascular disease, or 2 or more risk factors for developing cardiovascular disease.
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The MDRD formula has recently been criticized by several authors because it significantly overes timates the true values of GFR in patients with advanced CKD and underestimates in those with normal renal function or incipient CKD. The error associated with using the MDRD formula is fur ther enhanced by imprecision in serum creatinine measurement.
12 This prompted several groups of Serum glucose was measured in 145 patients (82% of the study group). In 87 patients (60% of the assays), increased glucose levels were observed (>110 mg/dl). Interestingly, only 27 patients had previously diagnosed diabetes. Certainly, these re sults should be inter preted with caution because in many patients serum glucose might not have been measured in the fasting state.
We also looked at the number of computed tomography (CT) scans performed in the study group. Fortythree patients (27% of the study group) underwent CT examination ordered by ED prior to subsequent hospital admission. There were 25 of 38 patients admitted later to the de partment of neurology, 6 of 49 to cardiology, and 4 of 6 to neurosurgery. The main indication for a CT scan was the suspicion of stroke. Serum creatinine and eGFR measurements were avail able only in 20 patients referred for CT (less than 50%); the results were 1.11 ±0.57 mg/dl and 89.9 ±32.8 ml/min/1.73 m 2 , respectively, indicating lack of advanced CKD in all but 1 patient from this group (serum creatinine, 3.3 mg/dl; eGFR, 19 ml/min/1.73 m 2 ).
dIscussIon The main finding of our study is that the ED does not fully utilize the available tools that might be helpful in the early detection of CKD. The parameters that are critical for early identification of CKD or CKD risk were usually as sessed in less than 50% of the patients who pre sented at the ED and were subsequently admitted to different hospital wards, although their clini cal profile strongly suggested high probability of CKD. While serum creatinine (and eGFR calcula tion) was measured in 50% of the patients and urea in 42%, urinalysis was performed only in 2.84% of the study group. Based exclusively on the criterion of eGFR, 64.8% of the patients with known eGFR and 32.4% of all patients admitted nonelectively to the hospital had CKD stages 2 to 5; when criterion of elevated serum creatinine was added, these figures decreased to 27.3% and 13.6%, respectively.
The latter numbers are in line with most of the epidemical data published to date. Accord ing to one of the latest reports from the Third experts to develop and validate alternative, an thropometrybased formulas, which are expect ed to be better correlated with true GFR. Among the most popular and widely used is the Chronic Kidney Disease Epidemiology Collaboration for mula. 13 This formula, used in a number of stud ies and various populations with renal disease, seems to have the best performance as compared with other methods of GFR calculation, although it cannot be used at this stage as a reference for mula. 14-17 Considering all drawbacks of the MDRD formula, it is possible to misclassify patients with normal renal function as having CKD stage 2 or even stage 3. By applying the criterion of low eGFR combined with elevated serum creatinine, we significantly decreased the number of patients with CKD with a shift towards its more advanced stages, which we believe greatly reduced the pos sibility of such a misclassification. Our study has several limitations. Patients' co morbidities, past medical history, medications taken, or followup after admission were not as sessed in detail. The "threemonth" criterion of CKD diagnosis was not fulfilled -patients were not reassessed after 3 months to confirm that kid ney damage was chronic. Nevertheless, the main objective of the study was to asses to what extent routine ED practices might be useful in identify ing patients with CKD -it was a snapshot of these practices. Excluding patients with lifethreatening conditions seemed reasonable, because many of them might have suffered from acute kidney in jury rather than from CKD (our methodology did not allow us to differentiate between the two groups). However, to our knowledge, there have been no other studies on the prevalence of CKD among emergency patients.
In conclusion, ED seems to be the right place to detect CKD using simple tools and may help identify numerous patients with this clinical enti ty. If serum creatinine, eGFR, or even blood pres sure are not measured, we risk overlooking a sig nificant percentage of patients who might benefit from early (onadmission) identification of CKD. This means that another chance to be diagnosed with CKD is lost, at least for some patients. Re nal community calls for action to detect patients with early CKD. It is of para mount importance because several clinical trials published recent ly have shown poor results of therapeutic inter ventions in advanced CKD (such as lipid or blood pressurelowering drugs, erythropoiesisstimu lating agents, medications that correct abnor malities of CKDrelated mineral and bone disor der, etc.).
18-22 On the other hand, patients who present at the ED and show a set of risk factors for CKD are not screened for this disease. Our results indicate that there is an urgent need for a structural screening program for CKD at this level of health care.
